nucli-sens easy mag automated platform Search Results


nucli-sens easy mag automated platform  (bioMerieux gmbh)
90
bioMerieux gmbh nucli-sens easy mag automated platform
Description of the studies examining cell-free DNA (cfDNA) for acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).
Nucli Sens Easy Mag Automated Platform, supplied by bioMerieux gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nucli-sens+easy+mag+automated+platform/nucli+sens+easy+mag+automated+platform/pmc08123338-10-12-17
Average 90 stars, based on 1 article reviews
nucli-sens easy mag automated platform - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
nucli sens easymag automated platform  (bioMerieux gmbh)
90
bioMerieux gmbh nucli sens easymag automated platform
Description of the studies examining cell-free DNA (cfDNA) for acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).
Nucli Sens Easymag Automated Platform, supplied by bioMerieux gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nucli-sens+easy+mag+automated+platform/nucli+sens+easymag+automated+platform/us10253370-184-12-17
Average 90 stars, based on 1 article reviews
nucli sens easymag automated platform - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Description of the studies examining cell-free DNA (cfDNA) for acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).

Journal: Cancers

Article Title: Role of Circulating Tumor DNA in Hematological Malignancy

doi: 10.3390/cancers13092078

Figure Lengend Snippet: Description of the studies examining cell-free DNA (cfDNA) for acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).

Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

Techniques: Isolation, Clinical Proteomics, Mutagenesis, Electrophoresis, Virus, Methylation, Clone Assay, Sequencing, Biomarker Discovery, Diagnostic Assay, Nucleic Acid Electrophoresis, Transplantation Assay